This site is intended for healthcare professionals

Real-world data from BIOSOLVE-IV registry confirms long-term safety and efficacy of Magmaris Resorbable Magnesium Scaffold- Biotronik

Read time: 1 mins
Last updated:19th May 2021
Published:19th May 2021
New, long-term follow-up data from the BIOSOLVE-IV real-world registry strengthens the clinical evidence for Biotronik’s Magmaris Resorbable Magnesium Scaffold (RMS) as a therapy option for patients with coronary artery disease.
Condition: Coronary Artery Disease
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest